Stifel Financial
ATRA icon

Stifel Financial’s Atara Biotherapeutics ATRA Stock Holding History

Stifel Financial’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-499
Closed -$20.1K – 3285
2023
Q2 		$20.1K Sell
499
-641
-56% -$36.2K ﹤0.01% 3285
2023
Q1 		$82.6K Buy
1,140
+30
+3% +$2.91K ﹤0.01% 3201
2022
Q4 		$91.1K Sell
1,110
-39
-3% -$4.06K ﹤0.01% 3145
2022
Q3 		$109K Buy
1,149
+728
+173% +$81.8K ﹤0.01% 3096
2022
Q2 		$82K Buy
421
+10
+2% +$1.63K ﹤0.01% 3179
2022
Q1 		$96K Sell
411
-12
-3% -$3.82K ﹤0.01% 3260
2021
Q4 		$167K Sell
423
-13
-3% -$5.47K ﹤0.01% 3185
2021
Q3 		$195K Buy
436
+14
+3% +$5.02K ﹤0.01% 3140
2021
Q2 		$164K Sell
422
-10
-2% -$3.57K ﹤0.01% 3173
2021
Q1 		$155K Buy
+432
New +$191K ﹤0.01% 3072

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return